Is Eli Lilly a Buy? Analyst Confidence Grows for 2025 | Nasdaq

Nov 5, 2024 · Analysts Conviction Firms: Eli Lilly Will Set a New High The first analyst revisions tracked by MarketBeat include reduced price targets, but the takeaway from the data is positive for shareholders.

25%
OFF

Is Eli Lilly A Buy? Analyst Confidence Grows For 2025 - Barchart.com

2 weeks from now

New highs are likely by early 2025. Eli Lilly's price pullback is an opportunity worth 25%, with analysts' sentiment firming around the $1000 level. New highs are likely by early 2025. ... Is …

barchart.com

25%
OFF

Is Eli Lilly A Buy? Analyst Confidence Grows For 2025

2 weeks from now

Nov 5, 2024 · Eli Lilly's stock is viewed positively by analysts, with expectations of a 25% price increase by early 2025. Despite a Q3 revenue miss, the company shows strong growth …

longportapp.com

$930.96
OFF

Expert Outlook: Eli Lilly And Co Through The Eyes Of 25 Analysts

2 weeks from now

Jul 24, 2024 · Analysts have recently evaluated Eli Lilly and Co and provided 12-month price targets. The average target is $930.96, accompanied by a high estimate of $1025.00 and a …

nasdaq.com

5%
OFF

Analysts Are Bullish On Top Healthcare Stocks: Eli Lilly & Co (LLY ...

2 weeks from now

1 day ago · The word on The Street in general, suggests a Strong Buy analyst consensus rating for Eli Lilly & Co with a $1057.00 average price target, implying a 33.5% upside from current …

businessinsider.com

$1.18
OFF

Eli Lilly And Company (LLY) Stock Forecast & Price Target

2 weeks from now

4 days ago · Eli Lilly and Company Bear Case. Investors should be bearish about investing in Eli Lilly and Co for these reasons: The company missed earnings expectations with $1.18 …

marketbeat.com

$955.64
OFF

Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock - Nasdaq

2 weeks from now

Aug 12, 2024 · Analysts have recently evaluated Eli Lilly and provided 12-month price targets. The average target is $955.64, accompanied by a high estimate of $1125.00 and a low …

nasdaq.com

1%
OFF

LLY, ABT, Or ISRG: Which "Strong Buy" Healthcare Stock Could

2 weeks from now

6 days ago · At $570, the average ISRG stock price target implies 5.1% upside potential.See more ISRG analyst ratingsConclusionWall Street is optimistic about the long-term prospects of …

nasdaq.com

37%
OFF

Eli Lilly (LLY) Stock Price Prediction And Forecast 2025-2030

2 weeks from now

21 hours ago · We expect Eli Lilly’s P/E ratio in 2025 to be 60 with an EPS of $19.11, resulting in a price target of $1140.00 This prediction is based on strong revenue growth of 18.37% to …

247wallst.com

FAQs about Is Eli Lilly a Buy? Analyst Confidence Grows for 2025 | Nasdaq Coupon?

Is Eli Lilly a good stock to buy in 2025?

Despite tepid results, analysts' consensus is firming around the $1000 level; the outlook and pipeline are robust. Ebglyss approval in Q3 will sustain the company's growth trajectory in 2025. 5 stocks we like better than Eli Lilly and Company. Eli Lilly’s NYSE: LLY market isn’t out of the weeds yet but will rebound strongly in 2025. ...

Should you buy Eli Lilly & Company?

MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list. While Eli Lilly and Company currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys. ...

Are Eli Lilly & Company (ell) stocks a good buy?

While Eli Lilly and Company currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ...

Is Eli Lilly & Co stock undervalued?

Current stock price is around $803.38, which may be perceived as undervalued given the company's growth prospects and recent analyst target prices ranging from $885.00 to $1,100.00. Investors should be bearish about investing in Eli Lilly and Co for these reasons: ...

Will Eli Lilly's market rebound in 2025?

Analyst Confidence Grows for 2025 Eli Lilly’s (NYSE: LLY) market isn’t out of the weeds yet but will rebound strongly in 2025. The Q3 results failed to spark a rally because of underperformance, but the salient details are that growth is robust, driving impressive profits, and is expected to accelerate in 2025. ...

What is the price target for Eli Lilly & Company (LLY)?

The highest price target for LLY is $1,250.00, while the lowest price target for LLY is $723.00. The average price target represents a forecasted upside of 27.48% from the current price of $786.15. Enter your email address to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors. ...